NPC1 and infection: The findings presented in Figs 5 and 6 indicate that the primary mechanism by which apilimod blocks EBOV entry and infection (Figs 1–4) is by blocking virus transport from early (EEA1+) endosomes to their site of fusion in NPC1+ endolysosomes.